Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹314 Cr₹266 Cr₹185 Cr₹236 Cr₹117 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹314 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹314 Cr
Mar2023₹266 Cr
Mar2022₹185 Cr
Mar2021₹236 Cr
Mar2020₹117 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹314 Cr
17.80
Mar2023 ₹266 Cr
44.29
Mar2022 ₹185 Cr
-21.77
Mar2021 ₹236 Cr
101.62
Mar2020 ₹117 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,459.2 Cr -4.5% -12.9% 62.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,135.0 Cr 2.6% -1.1% 38.3% Stock Analytics
DIVIS LABORATORIES ₹153,074.0 Cr -3.8% -1.9% 60.1% Stock Analytics
CIPLA ₹114,019.0 Cr -2.4% -5.2% 10.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,192.0 Cr -5.9% -9.6% 14.5% Stock Analytics
ZYDUS LIFESCIENCES ₹96,256.3 Cr -3.9% -0.3% 40.6% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.5%

-12.9%

62.5%

SENSEX

-0.6%

-2.9%

6.3%


You may also like the below Video Courses